NHC Submits Statement for the Record to House Committee on Energy and Commerce on ASAP Act Prepared Written Testimony Randall Rutta Chief Executive Officer, National Health Council United States House […]
Policy
NHC Responds to CMS CY 2027 Physician Fee Schedule Proposed Rule
NHC Responds to CMS CY 2027 Physician Fee Schedule Proposed Rule September 14, 2026 Mehmet Oz, MD, MBA Administrator Centers for Medicare & Medicaid Services Department of Health and Human […]
340B Policy and the Patient Perspective
340B Policy and the Patient Perspective Event Time: 8:00 a.m. ET – 12:00 p.m. ET Event Location: USC Capital Campus, Washington, DC Home Event Location & Travel Become a Sponsor […]
NHC Responds to CMS CY 2027 OPPS Proposed Rule
NHC Responds to CMS CY 2027 OPPS Proposed Rule August 31, 2026 Mehmet Oz, MD, MBA AdministratorCenters for Medicare & Medicaid Services Department of Health and Human Services 7500 Security […]
NHC Response to 340B Drug Pricing Integrity and Affordability for Patients Act Discussion Draft
NHC Response to 340B Drug Pricing Integrity and Affordability for Patients Act Discussion Draft August 28, 2026 The Honorable Bill Cassidy Chairman Committee on Health, Education, Labor, and Pensions United […]
NHC Comments on OIG Clinical Trial Participation RFI
NHC Comments on OIG Clinical Trial Participation RFI August 24, 2026 The Honorable T. March Bell Inspector General Office of Inspector General Department of Health and Human Services Cohen Building […]
NHC Comments on CMS Proposed Rule for Medicare Drug Price Negotiation Program IPAY 2029
NHC Comments on CMS Proposed Rule for Medicare Drug Price Negotiation Program IPAY 2029 August 17, 2026 Mehmet Oz, MD, MBA Administrator Centers for Medicare & Medicaid Services Department of […]
NHC Responds to Senate RFI on Drug Costs
NHC Responds to Senate RFI on Drug Costs August 17, 2026 The Honorable Ron Wyden Ranking Member Committee on Finance United States Senate Washington, DC 20510 Dear Ranking Member Wyden: […]
340B Policy Analysis and Discussion Webinar
340B Policy Analysis and Discussion Webinar Event Time: 11:00 a.m. ET – 12:00 p.m. ET Event Location: Virtual As policymakers and stakeholders consider changes to the 340B Drug Pricing Program, […]
NHC Comments on Medical Device User Fee Amendments Performance Goals and Procedures for fiscal years 2028 through 2032
NHC Comments on Medical Device User Fee Amendments Performance Goals and Procedures for Fiscal Years 2028 through 2032 August 6, 2026 Dockets Management Staff Food and Drug Administration 5630 Fishers […]